71 related articles for article (PubMed ID: 24912657)
1. Intracranial bleeding in acute promyelocytic leukemia treated with arsenic trioxide based regimens is associated with induction mortality but not with relapse.
Kulkarni UP; Selvarajan S; Fouzia NA; Lionel S; Nair SC; Balasubramanian P; Mani T; Abraham A; George B; Mathews V
Blood Cancer J; 2023 Jun; 13(1):94. PubMed ID: 37349334
[No Abstract] [Full Text] [Related]
2. Microgranular acute promyelocytic leukemia presenting with leukopenia and an unusual immunophenotype.
McDonnell MH; Smith ET; Lipford EH; Gerber JM; Grunwald MR
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):35-38. PubMed ID: 26806461
[TBL] [Abstract][Full Text] [Related]
3. Fertility and parenthood in patients with acute promyelocytic leukemia treated with Arsenic Trioxide and All-Trans retinoic acid.
Singh C; Saini M; Jain A; Lad D; Prakash G; Khadwal A; Naseem S; Malhotra P
Blood Cancer J; 2024 Jan; 14(1):14. PubMed ID: 38238308
[No Abstract] [Full Text] [Related]
4. Acute Promyelocytic Leukemia.
Winkler C
N Engl J Med; 2024 May; 390(17):e42. PubMed ID: 38683728
[No Abstract] [Full Text] [Related]
5. A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration.
Goto T; Nakamura N; Suzaki T; Shimazu R; Kaneda Y; Ikoma Y; Matsumoto T; Nakamura H; Kanemura N; Shimizu M
Ann Hematol; 2024 Apr; 103(4):1409-1410. PubMed ID: 38376572
[No Abstract] [Full Text] [Related]
6. Role of autophagy in acute myeloid leukemia therapy.
Zhang SP; Niu YN; Yuan N; Zhang AH; Chao D; Xu QP; Wang LJ; Zhang XG; Zhao WL; Zhao Y; Wang JR
Chin J Cancer; 2013 Mar; 32(3):130-5. PubMed ID: 22854065
[TBL] [Abstract][Full Text] [Related]
7. Recurrent RARG trinary fusion and ligand binding domain truncation in variant acute promyelocytic leukemia resistant to retinoic acid but sensitive to homoharringtonine-based therapy.
Chen X; Zhao Y; Zhou X; Chen J; Cao P; Wang F; Zhang Y; Wu P; Zhang L; Liu H
Int J Lab Hematol; 2023 Dec; 45(6):1016-1019. PubMed ID: 37605819
[No Abstract] [Full Text] [Related]
8. Evolution in treatment of acute promyelocytic leukemia: a major victory.
Tallman MS
Haematologica; 2024 Feb; 109(2):367-368. PubMed ID: 38299725
[No Abstract] [Full Text] [Related]
9. Diagnosis of acute promyelocytic leukemia based on routine biological parameters using machine learning.
Cheli E; Chevalier S; Kosmider O; Eveillard M; Chapuis N; Plesa A; Heiblig M; Andre L; Pouget J; Mossuz P; Theisen O; Alcazer V; Gugenheim D; Autexier N; Sujobert P
Haematologica; 2022 Jun; 107(6):1466-1469. PubMed ID: 35199507
[No Abstract] [Full Text] [Related]
10. Treating Pediatric Acute Promyelocytic Leukemia in India - Key Challenges and Lessons Learned.
Ganguly S; Bakhshi S
Indian J Pediatr; 2024 Jun; 91(6):535-536. PubMed ID: 38159153
[No Abstract] [Full Text] [Related]
11. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
[No Abstract] [Full Text] [Related]
12. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.
Vitoux D; Nasr R; de The H
Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032
[TBL] [Abstract][Full Text] [Related]
13. Sweet fruit from a poisonous kiss.
Liu D
J Hematol Oncol; 2010 May; 3():19. PubMed ID: 20509866
[No Abstract] [Full Text] [Related]
14. Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity.
Ng Liet Hing M; Ryland GL; Nguyen T; Tiong IS; Dun K; Ninkovic S; Nedumannil R; Westerman DA; Blombery PA; Chan KL; Bajel A
Br J Haematol; 2023 Aug; 202(4):893-896. PubMed ID: 37280781
[No Abstract] [Full Text] [Related]
15. Guest editorial: acute promyelocytic leukemia: change from "highly fatal to highly curable" leukemia.
Komatsu N
Int J Hematol; 2014 Jul; 100(1):16-7. PubMed ID: 24912657
[No Abstract] [Full Text] [Related]
16. APL, a model disease for cancer therapies?
de Thé H; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7136-9. PubMed ID: 11704841
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
